FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
26 letters match. Newest first.
-
DrugsTianjin Healthcare Medical Technology Co., Ltd.
Chinese API maker refused FDA records requests, and all its drugs now face a US import alert.
High risk -
DrugsSeema International
FDA warns Seema International over unclean API equipment, missing stability data, and quality-unit failures after inspection; APIs adulterated.
High risk -
FoodTurkana Food Inc.
Turkana Food, a New Jersey importer, lacked required supplier checks and records after a tahini Salmonella recall, FDA says.
High risk -
FoodEurobread Inc. dba First Harvest
FDA found Eurobread/First Harvest lacked required foreign supplier verification for imported Mini Patisseries tied to a Salmonella outbreak.
High risk -
DrugsEverlaan Organics, Inc. dba Maple Organics
FDA warns Maple Organics over OTC drug CGMP failures, unapproved new drugs, and misbranding.
High risk -
DrugsAspen Biopharma Labs Private Limited
FDA warns Aspen Biopharma Labs over current good manufacturing practice failures in active ingredient manufacturing after U.S. recall.
High risk -
DrugsZenzi Pharmaceutical Industries Pvt. Ltd.
Zenzi Pharmaceutical Industries refused FDA requests for records about prescription drugs made for the U.S. market.
High risk -
DrugsGlobal Calcium Pvt. Limited
FDA cites Global Calcium API plant for falsified records, deleted files, facility leaks and incomplete impurity profiles; products on Import Alert 66-40.
High risk -
DrugsViatris, Inc.
FDA warns Viatris that its Indore, India, drug plant had unreliable quality data and weak investigations.
High risk -
DrugsAkron Formulations India Private Limited
Akron Formulations India's over-the-counter drugs are adulterated due to manufacturing quality (CGMP) failures, including unqualified active ingredient (API) suppliers and inadequate microbial testing.
High risk -
FoodBacalao Giraldo, S.L.U.
FDA warns Spain's Bacalao Giraldo over inadequate HACCP controls for Clostridium botulinum in refrigerated and frozen desalted cod.
High risk -
DrugsEnviroServe Chemicals & Cleaners Ltd.
EnviroServe's SOPURE hand sanitizer had manufacturing-quality violations and was sold as an unapproved, misleadingly labeled drug.
High risk -
DrugsGFA Production Xiamen Co., Ltd.
GFA Production Xiamen failed CGMP for drugs, including process validation, cleaning, and lab controls.
High risk -
DrugsSaruhan Kimya Ve Temizlik Urunleri Sanayi Ticaret Anonim Sirketi Corlu Subesi
FDA found manufacturing violations at Turkish OTC drug maker, including missing identity, release, and stability testing for hand sanitizers.
High risk -
DrugsZhao Qing Longda Biotechnology Co. Ltd.
FDA says Zhao Qing Longda Biotechnology refused records access for OTC drugs, including children’s toothpaste, and placed its drugs on import alert.
High risk -
FoodLa Yongjia Trade Co.
FDA found Listeria in fresh enoki mushrooms imported by La Yongjia Trade Co., which lacked a Foreign Supplier Verification Program (FSVP).
High risk -
FoodARYZ Trading LLC
ARYZ Trading, a Michigan food importer, had no FSVP for imported dried mint, tahina and olive oil; FDA found Salmonella and pesticide residue.
High risk -
FoodNational Food Industries LLC
FDA cited Dubai snack maker National Food Industries for undeclared milk and other label violations and pest/preventive-control problems, leading to import alerts.
High risk -
DrugsMirfeel Korea Co., Ltd.
Mirfeel Korea's hand sanitizer contained benzene and had testing failures; FDA also says food-pouch packaging misbranded.
High risk -
FoodPatidar Trade, Inc.
Patidar Trade, Inc. lacked required foreign supplier safety plans for imported wheat flour, rice flour, and phool makhana, FDA says.
High risk -
DrugsIndiana Chem-Port
Indiana Chem-Port API manufacturer cited for CGMP deviations including dirty equipment, unvalidated processes, and cleaning failures.
High risk -
FoodHK Produce Group Inc. DBA Y2S Trading Inc.
FDA warned HK Produce Group/Y2S Trading that it lacked foreign supplier verification programs for enoki mushrooms tied to Listeria samples.
High risk -
DrugsSyntec Pharma Corp
FDA warned Syntec Pharma Corp, an API repackager in Farmingdale, New York, that weak cross-contamination controls and quality oversight made its drugs adulterated.
High risk -
FoodSTB Quarters, LLC
Chicago importer STB Quarters had no foreign supplier verification program for its imported tahini/sesame paste and sesame seeds.
High risk -
FoodKareem Mart Inc.
Kareem Mart lacked required FSVP records and written assurances for imported hummus, halwa and sesame breadsticks, FDA says.
High risk -
DrugsProfessional Compounding Centers of America dba PCCA
PCCA received adulterated drug ingredients from suppliers on FDA import alerts and failed adequate glycerin identity testing.
High risk